General Information | ATC Highlights
Rudolf Jaenisch received his M.D. at the University of Munich in 1967. After postdoctoral work at Princeton and Fox Chase Cancer Center, and five years as a Research Professor at the Salk Institute, he became Head of the Department of Tumor Virology at the Heinrich Pette Institute for Experimental Virology and Immunology. Since 1984 he has been a Founding Member of the Whitehead Institute and Professor of Biology at M.I.T. and in 2005 he established the Human Stem Cell Facility at the Whitehead.
Dr. Jaenisch is a pioneer in making transgenic mice, leading to some important advances in understanding cancer, neurological and connective tissue diseases, and developmental abnormalities. These mice have been used to explore basic questions such as the role of DNA modification, genomic imprinting, X chromosome inactivation, nuclear cloning, and, most recently, the nature of stem cells. The Jaenisch laboratory has used therapeutic cloning and gene therapy to rescue mice having a genetic defect and more recently, using a technique for turning skin cells into stem cells, they have cured mice of sickle cell anemia -- the first direct proof that these easily obtained cells can reverse an inherited disease.
Selected Honors and Awards:
1992- American Academy of Arts and Sciences, Fellow
1996 Boehringer Mannheim Molecular Bioanalytics Prize
2001 First Peter Gruber Foundation Award in Genetics
2002 Robert Koch Prize for Excellence in Scientific Achievement
2003- U.S. National Academy of Sciences, Member
2003 Charles Rodolphe Brupracher Foundation Cancer Award
2006 Max Delbrück Medal in Molecular Medicine
2006- German Academy of Natural Sciences Leopoldina, Member
2007 Vilcek Foundation Prize for Achievements of Prominent Immigrants
The ATC is excited to welcome Phillip Sharp, PhD as one of our 2009 State-of-the-Art Speakers.
"Phillip A. Sharp is Institute Professor at the David H. Koch Institute for Integrative Cancer Research (formerly the Center for Cancer Research) at the Massachusetts Institute of Technology. He received the Nobel Prize in Physiology or Medicine in 1993 for his landmark work on the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing. His lab has now turned its attention to understanding how RNA molecules act as switches to turn genes on and off (RNA interference). These newly discovered processes have revolutionized cell biology and could potentially generate a new class of therapeutics."
Dr. Sharp will speak on the topic of "RNA in Biology and Disease" on Sunday, May 31st, from 10:00 – 10:30 am.
ATC New Investigator Career Highlight Forum
The AST and ASTS have historically exhibited a strong commitment to career development by awarding grants to junior faculty and fellows. To further serve the mission of career development, a new highly interactive session will be held this year entitled the ATC New Investigator Career Highlight Forum. The purpose is to provide a mechanism by which the AST and ASTS can highlight the careers of past awardees by providing these promising individuals with an opportunity to present their research findings to a wide audience and obtain feedback from established investigators.